1338P TP53 truncating and missense mutations are linked to differential response to checkpoint blockade in patients with advanced non-small cell lung cancer (NSCLC)

Bibliographic Details
Title: 1338P TP53 truncating and missense mutations are linked to differential response to checkpoint blockade in patients with advanced non-small cell lung cancer (NSCLC)
Authors: Citarella, F., Russano, M., Fiorenti, M., La Cava, G., Pizzutilo, E.G., Martinelli, F., Pierri, S., Russo, A., Muscolino, P., Sapuppo, E., Marinello, A., Aldea, M., Besse, B., Filetti, M., Lombardi, P., Vitale, A., Buzzacchino, F., Cristofani, L., Lugini, A., Cortellini, A.
Source: In Annals of Oncology September 2024 35 Supplement 2:S848-S848
Database: ScienceDirect
More Details
ISSN:09237534
DOI:10.1016/j.annonc.2024.08.1393
Published in:Annals of Oncology
Language:English